REVELATION BIOSCIENCES, INC. Other Research and Development Expense
REVELATION BIOSCIENCES, INC. (REVB) reported Other Research and Development Expense of $131.58 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2026-08-06
- REVELATION BIOSCIENCES, INC. other research and development expense for the quarter ending 2026-06-30 was $131.58K, a 539.66% increase year-over-year.
- REVELATION BIOSCIENCES, INC. other research and development expense for the quarter ending 2026-03-31 was $179.59K, a 660.55% increase year-over-year.
- REVELATION BIOSCIENCES, INC. other research and development expense for the quarter ending 2025-12-31 was $99.46K, a 0.03% increase year-over-year.
- REVELATION BIOSCIENCES, INC. other research and development expense for the quarter ending 2025-09-30 was $24.90K, a 10.91% increase year-over-year.
- REVELATION BIOSCIENCES, INC. other research and development expense for fiscal 2025 was $168.54K, a 2.22% decline from fiscal 2024.
- REVELATION BIOSCIENCES, INC. other research and development expense for fiscal 2024 was $172.37K, a 39.08% decline from fiscal 2023.
- REVELATION BIOSCIENCES, INC. other research and development expense for fiscal 2023 was $282.95K.
| Period end | Other Research and Development Expense 3 month | Other Research and Development Expense 6 month | Other Research and Development Expense 9 month | Other Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $131.58K 10-Q · filed 2026-08-06 | $308.91K 10-Q · filed 2026-08-06 | $410.62K derived: sum of 3 quarters · filed 2026-08-06 | $435.52K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $179.59K 10-Q · filed 2026-05-07 | $279.04K derived: sum of 2 quarters · filed 2026-05-07 | $303.94K derived: sum of 3 quarters · filed 2026-05-07 | $324.51K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $99.46K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $124.35K derived: sum of 2 quarters · filed 2026-02-26 | $144.92K derived: sum of 3 quarters · filed 2026-08-06 | $168.54K 10-K · filed 2026-02-26 |
| 2025-09-30 | $24.90K 10-Q · filed 2025-11-06 | $45.47K derived: sum of 2 quarters · filed 2026-08-06 | $69.08K 10-Q · filed 2025-11-06 | $168.50K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $20.57K 10-Q · filed 2026-08-06 | $44.18K 10-Q · filed 2026-08-06 | $143.61K derived: sum of 3 quarters · filed 2026-08-06 | $166.05K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $23.61K 10-Q · filed 2026-05-07 | $123.04K derived: sum of 2 quarters · filed 2026-05-07 | $145.48K derived: sum of 3 quarters · filed 2026-05-07 | $257.66K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $99.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $121.87K derived: sum of 2 quarters · filed 2026-02-26 | $234.05K derived: sum of 3 quarters · filed 2026-02-26 | $172.37K 10-K · filed 2026-02-26 |
| 2024-09-30 | $22.45K 10-Q · filed 2025-11-06 | $134.63K derived: sum of 2 quarters · filed 2025-11-06 | $72.95K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $112.18K 10-Q · filed 2025-08-08 | $201.19K 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $89.02K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $282.95K 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |